ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.098,09
-0,50%
S&P 500
5.277,51
0,80%
US Dollar vs BRL
5,2463
0,01%
Bitcoin
67.615,02
0,20%
Brent Oil
81,295
0,00%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Aravive (delisted) (VSAR)

  7. Aravive (delisted) (VSAR) Notícias

VSAR

VERSARTIS, INC. (VSAR)

Aravive (delisted)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:VSAR
DataHoraFonteTítuloCódigoCompanhia
19/10/201817:14Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:VSARAravive (delisted)
17/10/201807:04Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:VSARAravive (delisted)
16/10/201819:34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VSARAravive (delisted)
16/10/201819:07Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:VSARAravive (delisted)
16/10/201818:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VSARAravive (delisted)
15/10/201808:00GlobeNewswire Inc.Aravive Biologics and Versartis Complete MergerNASDAQ:VSARAravive (delisted)
05/10/201817:47Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:VSARAravive (delisted)
20/09/201818:05Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:VSARAravive (delisted)
06/09/201817:22Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:VSARAravive (delisted)
06/09/201810:27Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:VSARAravive (delisted)
06/09/201807:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:VSARAravive (delisted)
04/09/201808:04Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:VSARAravive (delisted)
08/08/201817:25Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VSARAravive (delisted)
08/08/201817:16Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:VSARAravive (delisted)
07/08/201817:15GlobeNewswire Inc.Versartis Reports Second Quarter 2018 Financial Results and Reviews Recent DevelopmentsNASDAQ:VSARAravive (delisted)
03/08/201818:58Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:VSARAravive (delisted)
24/07/201817:15Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:VSARAravive (delisted)
10/07/201809:29Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VSARAravive (delisted)
04/06/201809:00GlobeNewswire Inc.Versartis Enters into Merger Agreement with Aravive Biologics to Form a Clinical-Stage Biopharmaceutical Company Advancing In...NASDAQ:VSARAravive (delisted)
08/05/201817:15GlobeNewswire Inc.Versartis Reports First Quarter 2018 Financial ResultsNASDAQ:VSARAravive (delisted)
11/04/201807:06Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:VSARAravive (delisted)
26/03/201817:05GlobeNewswire Inc.Eyenovia Appoints Three Industry Veterans to Board of DirectorsNASDAQ:VSARAravive (delisted)
06/03/201819:29Edgar (US Regulatory)Annual Report (10-k)NASDAQ:VSARAravive (delisted)
01/03/201818:05GlobeNewswire Inc.Versartis Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate UpdateNASDAQ:VSARAravive (delisted)
30/11/201711:00GlobeNewswire Inc.Report: Exploring Fundamental Drivers Behind Amerco, Caesars Entertainment, Air Products and Chemicals, Consolidated Edison, ...NASDAQ:VSARAravive (delisted)
26/10/201718:05GlobeNewswire Inc.Versartis Reports Third Quarter 2017 Financial Results and Provides Corporate UpdateNASDAQ:VSARAravive (delisted)
26/10/201718:05GlobeNewswire Inc.Versartis Hires Cowen to Assist in Evaluating Potential Strategic TransactionsNASDAQ:VSARAravive (delisted)
21/09/201717:30GlobeNewswire Inc.Versartis Announces Phase 3 VELOCITY Trial of Somavaratan in Pediatric Growth Hormone Deficiency Did Not Meet Primary Endpoin...NASDAQ:VSARAravive (delisted)
07/09/201717:05GlobeNewswire Inc.Versartis’ Twice-Monthly Somavaratan for Pediatric Growth Hormone Deficiency to be Featured in Oral and Poster Presentation...NASDAQ:VSARAravive (delisted)
05/09/201717:05GlobeNewswire Inc.Versartis Announces Expansion of Executive Leadership Team with Addition of Dr. Robert Gut as the Head of Global Clinical, M...NASDAQ:VSARAravive (delisted)
 Apresentando as notícias mais relevantes sobre:NASDAQ:VSAR

Seu Histórico Recente

USOTC
WRDLY
Worldline (PK)
LSE
75SB
Vodafone 37
TSXV
FSW
Fireswirl Technologies
LSE
SE32
First.abu 27
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados